Key points are not available for this paper at this time.
Calprotectin (MRP8/14, S100A8/S100A9, 27E10 antigen) is a heterodimer of two calcium-binding proteins present in the cytoplasm of neutrophils and expressed on the membrane of monocytes. Upon neutrophil activation or endothelial adhesion of monocytes, calprotectin is released and may be detected in serum or body fluids as potentially useful clinical inflammatory marker. The soluble form of calprotectin provides both bacteriostatic and cytokine-like effects in the local environment. When calprotectin metabolism is affected on a systemic level, the zinc-binding properties of protein may induce severe dysregulation of zinc homeostasis with severe clinical symptoms. The distribution of membrane form of calprotectin is restricted to monocytes and immature macrophages and the presence of calprotectin-positive infiltrating cells reflects the influx of mononuclear phagocytes to the site of inflammation. Calprotectin expression and release seems to be of particular importance in immune and immunopathological reactions.
Building similarity graph...
Analyzing shared references across papers
Loading...
Ilja Střı́ž
Institute of Clinical and Experimental Medicine
I Trebichavský
Czech Academy of Sciences
Physiological Research
Czech Academy of Sciences
Czech Academy of Sciences, Institute of Microbiology
Institute of Clinical and Experimental Medicine
Building similarity graph...
Analyzing shared references across papers
Loading...
Střı́ž et al. (Thu,) studied this question.
synapsesocial.com/papers/69d734f5779571b57e48f4ad — DOI: https://doi.org/10.33549/physiolres.930448
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: